-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 17, the Shanghai Drug Administration issued the "Several Opinions on Promoting the Healthy Development of Shanghai's Pharmaceutical Retail Industry (Consultation Draft)" (hereinafter referred to as the "Opinion Draft") to further optimize the business environment of the city's pharmaceutical retail industry
.
Retail companies open stores, the number must be balanced
Retail companies open stores, the number must be balancedThe draft opinion requires that in terms of the overall layout of pharmacies, it is necessary to follow the principle of facilitating the purchase of drugs by the masses, and optimize the distribution of retail stores of drug retail chain enterprises in the "hotspots" and "blind spots" regions of the city
.
Advocate that pharmaceutical retail companies should rationally treat the cancellation of the restriction on the distance between stores and individual pharmacies, open stores rationally, and lay out scientifically, and maintain a reasonable and balanced number of pharmaceutical retail companies throughout the city
Regarding the allocation of designated medical insurance pharmacies, the draft opinion emphasizes "balanced distribution".
Specifically, according to the permanent population of the medical service circle and the distribution of stores, the number of designated medical insurance pharmacies is gradually increased by classification, mainly divided into 4 points:
1.
Fill in the gaps
.
For medical service circles that have stores but no designated medical insurance pharmacies, on the basis of meeting relevant conditions, each medical service circle will add one medical insurance designated pharmacy
2.
Increase density
.
For medical service circles that already have designated medical insurance pharmacies, appropriate additional medical insurance designated pharmacies will be established in accordance with the density of permanent residents
3.
Encourage competition
.
Continue to support large economic pharmacies that can reasonably reduce prices and meet the requirements to be included in medical insurance designated points, and appropriately reduce the requirements for area and personnel qualifications to promote fair competition in the market
4.
Reasonable layout
.
For drug retail chain enterprises that are newly opened at the original site of designated medical insurance pharmacies, the procedures for designated application and agreement negotiation will be simplified, and their medical insurance designated qualifications can be retained on the basis of meeting relevant conditions
Pharmacy purchases can simplify the approval process
Pharmacy purchases can simplify the approval processThe draft opinion also proposes to improve the standardization and facilitation of examination and approval in the pharmaceutical retail industry
.
The company’s name, legal representative and domicile in the business license will be changed in conjunction with the corresponding changes in the drug business license, so that applicants can apply for one application and change more licenses at the same time
If a drug retail chain company acquires or merges with other drug retail companies, and the actual business address and licensing conditions have not changed, the process of handling the "Pharmaceutical Business License" can be simplified
.
Implement the reform of "one industry, one certificate" and reengineer the process of opening pharmacies by relying on the city's "one network to provide services" platform
In addition, according to the application, a single application and simultaneous processing will be implemented for the drug business license, medical device business license, food business license, and second-class medical device business filing for opening pharmacies
.
In terms of the digital transformation of pharmaceutical retail companies, the draft opinion also gives specific measures:
1.
Comprehensively expand the application of electronic certificates in retail pharmacies
.
Through data and technology empowerment, build a new model of digital governance in the pharmaceutical retail industry
2.
Assist residents in the last mile of medicine
.
Speed up the upgrade and transformation of medical insurance terminals in pharmacies, and realize medical insurance-related services through medical insurance electronic certificates or "codes with application"
.
On the basis of optimizing the basic functions of "Shanghai Pharmacy" APP drug query, pharmacy query, regulatory information query, pharmacist service, etc.
, further upgrade and expand the convenience service and publicity and education functions, and build it into the "last mile" service for citizens to use drugs.
Powerful tool
.
Wisdom supervision, strict investigation of the problems of licensed pharmacists
Wisdom supervision, strict investigation of the problems of licensed pharmacistsFor pharmacy professionals, the opinion draft expresses the need to promote smart supervision measures, such as the use of ID card verification and face recognition comparison technology for pharmacists and other pharmacists’ attendance attendance, to prevent the occurrence of chaos such as “attendance on behalf of licensed pharmacists” Elephant
.
At the same time, the "check-in" information of licensed pharmacists and pharmacists will be uploaded to the intelligent supervision system for special management drugs in real time, so that law enforcement personnel can conduct targeted on-site verification and disposal
.
It should be noted that the draft opinion emphasizes that it is necessary to continue to carry out special rectification of illegal behaviors in pharmacies, take the on-the-job management of licensed pharmacists as the focus of the rectification, and submit relevant information to the national licensed pharmacist registration system in accordance with relevant regulations.
Procedures, revoke its "Practicing Pharmacist Registration Certificate" and incorporate it into credit management, and make timely public announcements to effectively deter relevant violations of laws and regulations
.
In addition, the opinion draft also mentions exploring the development of remote pharmaceutical services for licensed pharmacists
.
On the premise of meeting the requirements of licensed pharmacists and pharmacists' basic equipment, explore the development of remote pharmaceutical services for licensed pharmacists, and rationally allocate and effectively use licensed pharmacist resources as a supplement to daily practicing services
.
Based on the establishment of a standardized remote review system and process, stores are allowed to conduct remote review through licensed pharmacists registered at the headquarters as a supplement to the prescription review and pharmaceutical services of the resident pharmacist
.
Meet the relevant conditions, allow online prescription drugs
Meet the relevant conditions, allow online prescription drugsFor Internet drug sales and circulation platforms, the opinion draft also provides relevant regulations
.
1.
Promote standardized management of drug online sales platforms
.
Ensure that drug network sellers and third-party drug network transaction platforms fully implement the main responsibility of the enterprise, and increase the inspection and monitoring of drug information display, prescription review and monitoring, sales management, distribution management, drug traceability, adverse reaction collection, complaint management and dispute resolution, etc.
The enforcement of the system
.
2.
Guide the standardized development of "Internet + drug circulation"
.
Support pharmaceutical retail companies to strengthen cooperation with Internet hospitals and third-party platforms for pharmaceutical online transactions, promote online and offline integrated development, promote the sharing and safe circulation of electronic prescription information, and foster emerging pharmaceutical e-commerce business formats
.
In addition, under the premise of ensuring the authenticity and reliability of the source of electronic prescriptions, online sales of prescription drugs other than the special management drugs prescribed by laws, administrative regulations and relevant state departments are allowed
.
Under the conditions of ensuring the quality and safety of medicines throughout the delivery process and the effective implementation of pharmaceutical services by licensed pharmacists, further standardize drug Internet retail services
.